Skip to main content
. 2021 Jul 30;13:709620. doi: 10.3389/fnagi.2021.709620

Table 2.

Summary of the AFM measurements with chondroitin sulfate proteoglycan (CSPG) manipulation.

(A) Young’s modulus of the chABC-treated tissue
GCL SGZ+HL
Control (n = 3) chABC (n = 3) Control (n = 3) chABC (n = 3)
152 ± 16 Pa (15) 211 ± 17 Pa (15) 176 ± 17 Pa (15) 217 ± 7 Pa (15)
(B) Young’s modulus of CS-treated tissue
GCL SGZ+HL
Control (n = 3) 5 mg/ml (n = 2) 15 mg/ml (n = 3) Control (n = 3) 5 mg/ml (n = 2) 15 mg/ml (n = 3)
200 ± 17 Pa (11) 133 ± 8 Pa (10) 63 ± 5 Pa (11) 243 ± 15 Pa (15) 129 ± 17 Pa (10) 98 ± 14 Pa (14)

*The “n” indicates the number of animals as well as the number of measured slices (one slice from each animal). **Italicized figures: number of measured points